NCT06997068 2026-04-17
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Mayo Clinic
Phase 2 Recruiting
Mayo Clinic
University of Michigan Rogel Cancer Center
Centre Oscar Lambret
City of Hope Medical Center
City of Hope Medical Center
Emory University
Maastricht Radiation Oncology
Case Comprehensive Cancer Center